The antibody-drug conjugate (ADC) puxitatug samrotecan (AZD8205) demonstrated a manageable safety profile consistent with similar ADCs and initial...

Cytovation ASA, a clinical stage oncology company focused on the development of its first─in─class bifunctional immunotherapy CY─101 (CyPep─1)...

INCY's INCB123667 data show the candidate's potential as a differentiated treatment option for cancers with increased cyclin E1 activity,...

Milan, Italy-: Almarai, a leading food and beverage company in the Middle East, participated in the 46th Congress of the European Society for Clinical...

WEDNESDAY, Sept. 11, 2024 -- For patients with resistant hypertension, a quadruple single pill is superior to triple therapy, according to a study...